Department of Pathology Microbiology and Immunology

C. diff uses toxic compound to fuel growth advantage

The findings of a new research study increase understanding of the molecular drivers of C. diff infection and point to novel therapeutic strategies aimed at a pathogen that causes about half a million infections in the U.S. each year.

VUMC to develop AI technology for therapeutic antibody discovery

The approach will address “bottlenecks” that slow the traditional antibody discovery process, and it aims to make it possible to generate monoclonal antibody therapies against any target of interest.

Jeffrey Rathmell, PhD. (photo by Donn Jones)

Jeffrey Rathmell named to leadership role in cancer research at the University of Chicago

Rathmell has been named chair of the Ben May Department for Cancer Research and director of the Ludwig Center at the University of Chicago, effective July 1.

Vanderbilt University School of Medicine fifth in the nation in NIH research funding

The NIH is the world’s largest public funder of biomedical research. VUSM, which received $586 million in direct and indirect NIH grant support in FY24, has been among the top 10 recipients of NIH funding among U.S. medical schools for nine of the past 15 years.

This year’s awardees are, from left, Stokes Peebles, MD, Ravi Shah, MD, John Gore, PhD, and Jeffrey Davidson, PhD. (photo by Erin O. Smith)

VUMC honors four translational scientists

Translational research brings discoveries from the laboratory and preclinical studies to clinical trials and studies in humans.

Mahlon Johnson, former Vanderbilt pathologist whose story was featured on ‘60 Minutes,’ dies at 70

Dr. Johnson was performing an autopsy in 1992 when his hand slipped and he sliced through his protective gloves. He cut his finger and infected himself with AIDS.

1 2 3 30